Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-013261

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Khoso Baluch
Officer — Chief Executive Officer · Director
Period of report
Nov 26, 2018
Accepted (ET)
Nov 27, 2018 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 27, 2018P21,500$1.21A250,373D
Common StockNov 26, 2018P3,500$1.28A228,873D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F2$2.52holding————Sep 30, 2026Common Stock1,250,0001,250,000D
Stock Option (Right to Buy Common Stock)F3$2.52holding————Sep 30, 2026Common Stock300,000300,000D
Stock Option (Right to Buy Common Stock)F4$2.52holding————Sep 30, 2026Common Stock300,000300,000D

Explanation of responses